BATS BZX Real-Time Price
As of 9:39am ET
| +0.14 / +0.28%|
The 5 analysts offering 12-month price forecasts for KYTHERA Biopharmaceuticals Inc have a median target of 61.00, with a high estimate of 85.00 and a low estimate of 50.00. The median estimate represents a +23.11% increase from the last price of 49.55.
The current consensus among 5 polled investment analysts is to Buy stock in KYTHERA Biopharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.